AngioDynamics sheds Irish manufacturing operation
This article was originally published in Clinica
Citing its strategic decision to exit the cardiovascular market in order to focus on interventional radiology, AngioDynamics Inc has sold its Enniscorthy, County Wexford factory to its management, backed by two of Ireland's leading venture capital companies.
You may also be interested in...
HAL Allergy Group, developer of products for allergy diagnostics and allergen immunotherapy, promoted its principal scientist to chief R&D officer; Starkey Hearing Technologies brought on new health and business development execs to expand its global footprint; and more.
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.